US 12221452
Synthesis of cantharidin
granted A61PA61P17/00
Quick answer
US patent 12221452 (Synthesis of cantharidin) held by Verrica Pharmaceuticals Inc. expires Mon Feb 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Verrica Pharmaceuticals Inc.
- Grant date
- Tue Feb 11 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 06 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61P, A61P17/00